Total Payments
$2,058
2024 Payments
$608.17
Companies
7
Transactions
57
Medicare Patients
3,005
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$1,898 (92.2%)
Travel$160.20 (7.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,898 | 56 | 92.2% |
| Travel and Lodging | $160.20 | 1 | 7.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| KCI USA, Inc. | $458.48 | 10 | $0 (2023) |
| ABBVIE INC. | $442.68 | 35 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $395.72 | 4 | $0 (2024) |
| Melinta Therapeutics, LLC | $362.29 | 3 | $0 (2024) |
| Penumbra, Inc. | $240.32 | 2 | $0 (2023) |
| Becton, Dickinson and Company | $123.96 | 1 | $0 (2024) |
| Solventum Corporation | $34.30 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $608.17 | 23 | ABBVIE INC. ($199.91) |
| 2023 | $293.56 | 9 | KCI USA, Inc. ($134.83) |
| 2022 | $659.39 | 14 | KCI USA, Inc. ($294.15) |
| 2021 | $496.63 | 11 | Paratek Pharmaceuticals, Inc. ($270.72) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $8.81 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/30/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $2.88 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/24/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $4.52 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/03/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $5.03 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/26/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/19/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/18/2024 | Becton, Dickinson and Company | Crosser iQ (Device) | Food and Beverage | In-kind items and services | $123.96 | General |
| Category: Vascular/Oncology | ||||||
| 09/11/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/29/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/27/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/02/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/31/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $4.58 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/29/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/20/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/21/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/16/2024 | Solventum Corporation | ACTIV.A.C. (Device), V.A.C. DERMATAC, PROMOGRAN PRISMA | Food and Beverage | Cash or cash equivalent | $18.90 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
| 04/04/2024 | Melinta Therapeutics, LLC | Kimyrsa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ANTIBIOTICS | ||||||
| 03/06/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ANTIBIOTIC | ||||||
| 02/29/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/22/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/12/2024 | Solventum Corporation | 3M Coban (Device), ACTIV.A.C., PROMOGRAN PRISMA | Food and Beverage | Cash or cash equivalent | $15.40 | General |
| Category: Tapes and Wraps | ||||||
| 01/30/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/17/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $7.13 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/18/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/21/2023 | KCI USA, Inc. | V.A.C. VERAFLO (Device) | Food and Beverage | Cash or cash equivalent | $57.94 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 389 | 1,146 | $158,645 | $58,158 |
| 2022 | 12 | 687 | 1,875 | $279,829 | $100,349 |
| 2021 | 14 | 953 | 3,719 | $635,547 | $268,855 |
| 2020 | 13 | 976 | 4,069 | $1.7M | $729,595 |
Total Patients
3,005
Total Services
10,809
Medicare Billing
$1.2M
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2023 | 66 | 164 | $34,276 | $12,150 | 35.4% |
| 11045 | Removal of skin and tissue, each additional 20.0 sq cm or less | Office | 2023 | 14 | 358 | $25,915 | $9,274 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 103 | $19,109 | $8,273 | 43.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 39 | 156 | $19,667 | $7,922 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 116 | $14,730 | $6,417 | 43.6% |
| 97610 | Therapy procedure using ultrasound | Office | 2023 | 14 | 18 | $17,912 | $4,827 | 27.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 24 | 76 | $5,199 | $2,527 | 48.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $5,378 | $2,049 | 38.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 23 | $5,470 | $1,909 | 34.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 13 | $2,343 | $951.00 | 40.6% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2023 | 22 | 25 | $5,229 | $947.28 | 18.1% |
| 11045 | Removal of skin and tissue, each additional 20.0 sq cm or less | Facility | 2023 | 12 | 44 | $3,185 | $684.53 | 21.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 28 | 31 | $232.50 | $227.85 | 98.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 133 | 683 | $86,120 | $31,528 | 36.6% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2022 | 82 | 213 | $44,523 | $15,731 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 88 | 279 | $35,506 | $15,130 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 107 | $19,898 | $8,487 | 42.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 89 | 91 | $21,643 | $7,699 | 35.6% |
| 11045 | Removal of skin and tissue, each additional 20.0 sq cm or less | Office | 2022 | 23 | 176 | $12,737 | $4,728 | 37.1% |
| 11047 | Removal of bone, each additional 20.0 sq cm or less | Facility | 2022 | 12 | 50 | $10,953 | $3,365 | 30.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 34 | 40 | $7,208 | $2,645 | 36.7% |
| 11044 | Removal of bone, 20.0 sq cm or less | Facility | 2022 | 17 | 17 | $9,331 | $2,615 | 28.0% |
| 15271 | Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | Office | 2022 | 12 | 26 | $6,555 | $2,586 | 39.5% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2022 | 59 | 63 | $13,176 | $2,392 | 18.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $6,510 | $1,988 | 30.5% |
About Amanda Hooper, ACNP
Amanda Hooper, ACNP is a Registered Nurse healthcare provider based in Monroe, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/13/2011. The National Provider Identifier (NPI) number assigned to this provider is 1215232731.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Hooper, ACNP has received a total of $2,058 in payments from pharmaceutical and medical device companies, with $608.17 received in 2024. These payments were reported across 57 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,898).
As a Medicare-enrolled provider, Hooper has provided services to 3,005 Medicare beneficiaries, totaling 10,809 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Acute Care
- Location Monroe, LA
- Active Since 01/13/2011
- Last Updated 05/22/2019
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1215232731
Products in Payments
- NUZYRA (Drug) $395.72
- Kimyrsa (Drug) $362.29
- DALVANCE (Drug) $347.20
- V.A.C. DERMATAC (Device) $307.86
- Indigo System (Device) $240.32
- Crosser iQ (Device) $123.96
- TEFLARO (Drug) $95.48
- V.A.C. VERAFLO (Device) $91.27
- ACTIV.A.C. (Device) $78.25
- 3M Coban (Device) $15.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Monroe
Cynthia Turner
Registered Nurse — Payments: $4,495
Registered Nurse $4,495
Morgan O'neal, Agacnp, AGACNP
Registered Nurse — Payments: $3,720
Registered Nurse $3,720
Jennifer Price
Registered Nurse — Payments: $1,975
Registered Nurse $1,975
Brandon Baker
Registered Nurse — Payments: $1,687
Registered Nurse $1,687
Karen Parker, Fnp, FNP
Registered Nurse — Payments: $1,475
Registered Nurse $1,475
Rebecca Haynes, Cpnp, CPNP
Registered Nurse — Payments: $1,356
Registered Nurse $1,356